A

Alkermes plc
D

ALKS

29.340
USD
-0.70
(-2.33%)
مغلق
حجم التداول
84,587
الربح لكل سهم
2
العائد الربحي
-
P/E
14
حجم السوق
4,838,203,702
أصول ذات صلة
A
ACAD
0.450
(2.09%)
21.990 USD
A
ALK
0.620
(1.24%)
50.700 USD
A
ALX
-2.470
(-1.14%)
214.040 USD
E
EBS
-0.11000
(-1.69%)
6.39000 USD
INCY
INCY
-0.250
(-0.39%)
64.250 USD
المزيد
الأخبار المقالات

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.